sponsored byAAAS Golden Fund




Forgot Password?

Press Releases

Breaking News

Science Business

Grants, Awards, Books



Science Agencies
on EurekAlert!

US Department of Energy

US National Institutes of Health

US National Science Foundation


Submit a Calendar Item


Links & Resources


RSS Feeds

Accessibility Option On


Portal Home


Background Articles

Research Papers


Links & Resources

Disease in the Developing World

News Releases

Key: Meeting M      Journal J      Funder F

Showing releases 876-900 out of 1332.

<< < 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>

Public Release: 29-Apr-2016
Stansfield honored by Southern Society for Pediatric Research
Dr. Brian K. Stansfield, neonatologist at Children's Hospital of Georgia and a 2004 graduate of the Medical College of Georgia at Augusta University, has received the 2016 Clinical Science Young Investigator Award from the Southern Society for Pediatric Research.
American Heart Association, US Department of Defense

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 29-Apr-2016
Science Advances
Ebola virus genome provides clues to repeated disease 'flare-ups' in Western Africa
Ebola virus samples taken from Liberian patients in June 2015 are genetically similar to other Ebola virus sequences from Western Africa, according to research published today in Science Advances. The study sheds light on several aspects of the 'flare-ups' that have occurred in Liberia since the country was declared free of the disease. Among the findings: These cases were not a re-introduction from a neighboring country, but came from a persistently infected source within Liberia.
Defense Threat Reduction Agency, Global Emerging Infections System, US Centers for Disease Control and Prevention, Global Biosurveillance Technology Initiative, US Department of Defense, National Institutes of Health, and others

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 29-Apr-2016
Journal of Clinical Microbiology
HPV infection can be identified in self-collected vaginal swabs
High risk, potentially cancer causing human papillomavirus infections are common among women in Papua New Guinea. But self sampling with vaginal swabs may provide materials that screen as accurately as the more labor-intensive approach using cervical samples obtained by clinicians. This finding is critical to developing same day screening and treatment, which is key to ensuring that women with precancerous lesions are treated in this largely unconnected (electronically) country, and in others like it.

Contact: Aleea Khan
American Society for Microbiology

Public Release: 28-Apr-2016
Journal of Women's Health
African-American women with ovarian cancer -- can obesity mask early symptoms?
African-American women with ovarian cancer are more likely to die from the disease than are White women and they are also much more likely to be obese. These factors may be linked by the new finding that excess abdominal fat in overweight and obese women could interfere with the detection of early symptoms of ovarian cancer, as presented in a study published in Journal of Women's Health.

Contact: Kathryn Ryan
Mary Ann Liebert, Inc./Genetic Engineering News

Public Release: 28-Apr-2016
USAMRIID receives Technology Transfer Award for experimental Ebola treatment
Scientists from the US Army Medical Research Institute of Infectious Diseases were recognized for their work on ZMapp, a therapeutic monoclonal antibody 'cocktail' designed to treat Ebola virus infection, at the Federal Laboratory Consortium for Technology Transfer national meeting held this week. ZMapp made headlines in August 2014 when it was used to treat two American medical workers in Liberia, who both recovered. USAMRIID research protects US service members and contributes to global public health.

Contact: Caree Vander Linden
US Army Medical Research Institute of Infectious Diseases

Public Release: 28-Apr-2016
Scientific Reports
UEA drug research could prevent secondary cataract
Scientists at the University of East Anglia may have found a way to prevent complications from surgery to treat cataract -- the world's leading cause of blindness. It's estimated that by the year 2020, 32 million people will need cataract surgery -- which works well to restore vision, but can lead to 'secondary cataract' forming. The research team reveal how a new focus for drugs to treat age-related macular degeneration could reduce the need for millions of follow-up eye operations.
Fight for Sight

Contact: Lisa Horton
University of East Anglia

Public Release: 28-Apr-2016
PLOS Neglected Tropical Diseases
A 'tropical' parasitic disease emerges in the Canadian Arctic
An outbreak of an intestinal parasite common in the tropics, known as Cryptosporidium, has been identified for the first time in the Arctic. The discovery was made in Nunavik, Quebec, by a team from the Research Institute of the McGill University Health Centre. The discovery, which was documented in the journal PLoS Neglected Tropical Diseases, could have long-term implications for the health of children in Nunavik and Nunavut's communities.
Institut national de santé publique du Québec, Canadian Institutes for Health Research, ArticNET, the Network of Centres of Excellence of Canada, Natural Sciences and Engineering Research Council of Canada

Contact: Julie Robert
514-934-1934 x71381
McGill University Health Centre

Public Release: 27-Apr-2016
Grand Challenges in Parkinson's Disease
Founder of movement disorders field to receive Parkinson's award
In honor of his immeasurable contributions to the study and treatment of movement disorders such as Parkinson's disease, Van Andel Research Institute (VARI) will present renowned neuroscientist and clinician Stanley Fahn, M.D., with the 2016 Jay Van Andel Award for Outstanding Parkinson's Disease Research. The award ceremony and Fahn's accompanying lecture will kick off VARI's annual Grand Challenges in Parkinson's Disease symposium, which will be held Sept. 26-27 at the Institute in Grand Rapids, Mich.

Contact: Beth Hinshaw Hall
Van Andel Research Institute

Public Release: 26-Apr-2016
PLOS Neglected Tropical Diseases
Zika present in Americas longer than previously thought
The Zika virus was present in Haiti several months before the first Zika cases were identified in Brazil, according to new research by infectious-disease specialists at the University of Florida.

Contact: Glenn Morris
University of Florida

Public Release: 26-Apr-2016
Nature Structural & Molecular Biology
TSRI scientists reveal secrets of a deadly virus family
Scientists at the Scripps Research Institute have solved the structure of the biological machinery used by a common virus to recognize and attack human host cells. The new structure gives scientists the first view of the glycoprotein of lymphocytic choriomeningitis virus (LCMV), present on every continent except Antarctica. The research reveals important traits in LCMV and points to possible drug targets on LCMV's close relative: Lassa virus.
National Institutes of Health, Burroughs Wellcome Fund

Contact: Madeline McCurry-Schmidt
Scripps Research Institute

Public Release: 26-Apr-2016
The $60 billion question -- can we prevent norovirus?
Each year, norovirus causes over 200,000 deaths and a global economic burden of $60 billion. In a new PLOS Collection -- 'The Global Burden of Norovirus & Prospects for Vaccine Development' -- global norovirus experts fill critical knowledge gaps and provide key information to further development of a much-needed vaccine.
US Centers for Disease Control and Prevention, Bill and Melinda Gates Foundation

Contact: Nathaniel Gore

Public Release: 25-Apr-2016
Vitamin D insufficiency, low rate of DNA methylation in black teens may increase disease risk
Low levels of vitamin D in black teens correlates with low activity of a major mechanism for controlling gene expression that may increase their risk of cancer and other disease, researchers report.
American Heart Association

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 21-Apr-2016
Nature Biotechnology
Infectious outbreaks must be combatted strategically, Dartmouth-HHS experts argue
New funding is not enough to guarantee success against emerging infectious diseases around the world. Rather, good governance, a long-term technology investment strategy and strong product management skills are essential, say a Dartmouth College researcher and her co-author.

Contact: John Cramer
Dartmouth College

Public Release: 21-Apr-2016
The Lancet
Reducing infectious malaria parasites in donated blood could help prevent transmission
A technique for reducing the number of infectious malaria parasites in whole blood could significantly reduce the number of cases of transmission of malaria through blood transfusion, according to a collaboration between researchers in Cambridge, UK, and Kumasi, Ghana.
Terumo BCT

Contact: Craig Brierley
University of Cambridge

Public Release: 20-Apr-2016
Where next for Zika virus?
A new global risk map reveals priority regions where authorities could intervene to control the vector mosquito population and where surveillance of the virus should be concentrated in order to improve rapid outbreak response and clinical diagnosis.

Contact: Zoe Dunford

Public Release: 20-Apr-2016
Parts of Europe may be exposed to dengue outbreaks
Global travel and climate change increase the risk for epidemics of the mosquito-borne dengue virus, and potentially other climate-sensitive infectious diseases, spreading into temperate areas. This according to a doctoral dissertation at Umeå University in Sweden.

Contact: Daniel Harju
Umea University

Public Release: 20-Apr-2016
Taking aspirin could increase cancer survival by 20 percent
Patients receiving cancer treatment could increase their chance of survival by up to 20 percent and help stop their cancer from spreading by taking a low dose of aspirin, new research suggests.

Contact: Peter Elwood
Cardiff University

Public Release: 19-Apr-2016
Two-vaccine Ebola regimen shows promise in early-stage clinical trial
An immunization regimen using two Ebola vaccine candidates was safe, well-tolerated and induced an immune response in healthy adult volunteers in a Phase 1 clinical trial. Results from the study are described in the April 19th issue of the Journal of the American Medical Association. NIAID has supported the development and testing of the two investigational vaccines: Ad26.ZEBOV, developed by Crucell Holland B.V., and MVA-BN-Filo, developed by Bavarian Nordic.
NIH/National Institute of Allergy and Infectious Diseases

Contact: Jennifer Routh
NIH/National Institute of Allergy and Infectious Diseases

Public Release: 19-Apr-2016
PLOS Neglected Tropical Diseases
Scientists describe new research model to enhance Zika virus research
Researchers at the University of Wisconsin-Madison School of Veterinary Medicine have developed one of the first mouse models for the study of Zika virus. The model will allow researchers to better understand how the virus causes disease and aid in the development of antiviral compounds and vaccines.

Contact: Matthew Aliota
University of Wisconsin-Madison

Public Release: 19-Apr-2016
Association for Chemoreception Sciences (AChemS) 38th Annual Meeting
A small dose of E. coli wall has big impact on the sweet tooth
Putting just a tiny piece of the wall of detoxified E. coli into their gut make mice lose their natural sweet tooth, researchers report.

Contact: Toni Baker
Medical College of Georgia at Augusta University

Public Release: 19-Apr-2016
PLOS Medicine
Clinical trial for experimental Ebola drug publishes results
Results of the Wellcome Trust funded trial of the experimental anti-Ebola drug TKM-130803 published in PLOS Medicine. Using a novel approach designed to get rapid indications of a drug's effectiveness, the trial showed that at the dose given the drug did not improve survival compared to historic controls.
Wellcome Trust

Contact: Tom Calver
University of Oxford

Public Release: 19-Apr-2016
Study examines safety, immune response of candidate Ebola vaccines
In a study appearing in the April 19, 2016 issue of JAMA, Matthew D. Snape, F.R.C.P.C.H., M.D., of the University of Oxford, United Kingdom, and colleagues conducted a phase 1 trial to evaluate the tolerability and immunogenicity of two candidate Ebola vaccines, an adenovirus type 26 vector vaccine (Ad26.ZEBOV), and a modified Ankara vector vaccine (MVA-BN-Filo).

Contact: Matthew D. Snape, F.R.C.P.C.H., M.D.
The JAMA Network Journals

Public Release: 19-Apr-2016
Report: Stagnant US funding for tools against disease threats leaves world at serious risk
Even as Congress grapples with the White House on how to fund an emergency response to fight Zika virus, a new report warns that overall underfunding for development of lifesaving tools against neglected global diseases is putting the United States and the world at risk, and that emergency funding can't be allowed to substitute for sustained US investment in research and development (R&D) of global health technologies.

Contact: Katy Lenard
Global Health Technologies Coalition

Public Release: 18-Apr-2016
Journal of Biological Chemistry
Discovery of enzyme in the sleeping sickness parasite streamlines drug development
Researchers from Umeå University in Sweden have discovered that the single-celled parasite causing African sleeping sickness has a defense mechanism against potential pharmaceuticals under development against the disease. The deadly parasite has an enzyme that can cleave and hence disarm adenosine analogue pharmaceuticals. This according to a study recently published in the Journal of Biological Chemistry.

Contact: Daniel Harju
Umea University

Public Release: 18-Apr-2016
New TB clinical trial data-sharing platform available for researchers
C-Path, TDR, TB Alliance, and St. George's, University of London, announce the launch of the TB-Platform for Aggregation of Clinical TB Studies (TB-PACTS): a database designed to catalyze tuberculosis (TB) research by curating and standardizing trial data from the REMoxTB, RIFAQUIN, and OFLOTUB clinical trials, and making them available to researchers. Having these data under one platform helps inform policymaking and drug development, ultimately benefiting TB patients.

Contact: Kissy Black
Critical Path Institute (C-Path)

Showing releases 876-900 out of 1332.

<< < 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 > >>